{"id":"NCT00648895","sponsor":"Forest Laboratories","briefTitle":"A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients","officialTitle":"Effect of Nebivolol on Forearm Vasodilation, Nitric Oxide Bioavailability, and Oxidative Stress in Patients With Stage 1/2 Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2009-07","completion":null,"firstPosted":"2008-04-01","resultsPosted":"2010-09-20","lastUpdate":"2010-09-20"},"enrollment":12,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Hypertension"],"interventions":[{"type":"DRUG","name":"Nebivolol","otherNames":["Bystolic (TM)"]},{"type":"DRUG","name":"Metoprolol ER (TM)","otherNames":["Toprol XL (TM)"]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The study is designed to compare the effects of nebivolol (10, 20, 40mg/day) with another beta blocker, extended-release metoprolol, at a range of doses. Its purpose is to study the mechanism of action of nebivolol on forearm blood flow, nitric oxide availability and other biomarkers.","primaryOutcome":{"measure":"Percentage Change From Baseline to End of Treatment for the Difference Between the Post-ischemia and Pre-ischemia Forearm Vascular Resistance (FVR).","timeFrame":"Before treatment and after 10 weeks","effectByArm":[],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":6},"commonTop":["Back pain","Nasopharyngitis","Hypoacusis","Cataract","Abdominal discomfort"]}}